Metropolitan Life Insurance Company (MetLife)’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio THRN Stock Details THRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-906	Closed	-$9.23K	–	2423
2023 Q3	$9.23K	Buy	+906	New	+$6.9K	﹤0.01%	2244

Metropolitan Life Insurance Company (MetLife)'s THRN Position: Q4 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q4 2023, closing a stake of 906 shares — an estimated $9.23K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in THRN in Q3 2023 and held it in 1 quarter. The position peaked at $9.23K in Q3 2023. 0 funds tracked by Wall St. Rank hold THRN as of Q4 2023.

Metropolitan Life Insurance Company (MetLife) reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 906 Thorne Healthtech, Inc. Common Stock shares in Q4 2023, an estimated $9.23K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Thorne Healthtech, Inc. Common Stock in Q3 2023 and held it in 1 quarter.
Metropolitan Life Insurance Company (MetLife)'s Thorne Healthtech, Inc. Common Stock position peaked at $9.23K in Q3 2023.
0 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q4 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2023, filed 14 Feb 2024.